REAGERA edu: Responding to Elder Abuse in GERiAtric Care: Educational Intervention

Sponsor
Region Östergötland (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05065281
Collaborator
Linkoeping University (Other), Region Jönköping County (Other), Linnaeus University (Other)
750
Enrollment
4
Locations
2
Arms
21.4
Anticipated Duration (Months)
187.5
Patients Per Site
8.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The prevalence of elder abuse has been reported between 10-15% in international studies. Elder abuse may include both physical, emotional, sexual and financial abuse as well as neglect and it occurs at the hand of both professionals and family members, including adult children and intimate partners. Elder abuse has been associated with psychological ill-health, disability, increased hospitalization, emergency department use and admission to nursing facilities. Elder abuse is however often unknown to health care providers. Older adults are hesitant to disclose abuse and health care providers are often reluctant to ask questions.

In this study an interactive educational model for health care professionals about elder abuse will be tested. The model consist of theoretical lectures, brief films showing patient encounters, group discussions and forum play, a form of participatory theater. Both group discussions and forum play will be using case scenarios as a cornerstone.

The validated questionnaire REAGERA-P will be used for self-reported measures

Condition or DiseaseIntervention/TreatmentPhase
  • Other: Education
N/A

Detailed Description

Please refer to the uploaded study protocol and statistical analysis plan for a detailed description of the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
750 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Non-randomized stepped wedge cluster trialNon-randomized stepped wedge cluster trial
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Responding to Elder Abuse in GERiAtric Care: Educational Intervention for Health Care Providers
Actual Study Start Date :
Sep 16, 2021
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

ArmIntervention/Treatment
Experimental: Education

Participants that have undergone the educational intervention

Other: Education
Training for health care professionals on how to identify and manage cases of elder abuse among their patients

No Intervention: Waitlist

Participants still waiting to cross over to intervention arm

Outcome Measures

Primary Outcome Measures

  1. Change between baseline and follow up concerning asking questions about abuse, as reported in the questionnaire REAGERA-P [Baseline, 6 month follow up, 12 month follow up, 18 month follow up]

    Self-report measure of asking older patients about abusive experience. Will be measure both as a dichotomous value (have ever asked questions during the last 6 months) as well as a frequency measure where participants report how often they have asked patients questions about abuse during the last 6 months (on a scale from 0 to 10 or more)

Secondary Outcome Measures

  1. Change between baseline and follow up concerning adequate follow up, as reported in the questionnaire REAGERA-P [Baseline, 6 month follow up, 12 month follow up, 18 month follow up]

    Frequency of respondents reporting that identified cases of elder abuse were given adequate follow up

  2. Change between baseline and follow up concerning self-reported hesitancy for asking questions about elder abuse, as reported in the questionnaire REAGERA-P [Baseline, 6 month follow up, 12 month follow up, 18 month follow up]

    Frequency of respondents reporting that they have suspected cases of elder abuse but refrained from asking questions

  3. Degree of changed practice as reported in the questionnaire REAGERA-P [6 month follow up]

    Frequency of participants self-reporting that they have changed their working practices as a result of the educational intervention

  4. Change between baseline and follow up concerning self-efficacy, as reported in the questionnaire REAGERA-P [Baseline, Immediate post-intervention, 6 month follow up, 12 month follow up, 18 month follow up]

    Self-reported self-efficacy for asking questions about elder abuse and managing the response

  5. Change between baseline and follow up concerning perceived individual level barriers (1), as reported in the questionnaire REAGERA-P [Baseline, immediate post-intervention, 6 month follow up, 12 month follow up, 18 month follow up]

    Self-reported perceived individual level barriers for asking questions about abuse: a) Worrying about a) negative reactions from the patient or b) negative consequences for the patient-provider relationship if asking questions about abuse c) Worrying about not being able to give proper follow up

  6. Change between baseline and follow up concerning perceived individual level barriers (2), as reported in the questionnaire REAGERA-P [Baseline, 6 month follow up, 12 month follow up, 18 month follow up]

    Self-reported perceived individual level barriers for asking questions about abuse: d) Own lack of awareness as a barrier e) Knowledge about judicial concerns f) Knowledge on how to properly document cases in the patient chart

  7. Change between baseline and follow up concerning perceived organizational level barriers, as reported in the questionnaire REAGERA-P [Baseline, 6 month follow up, 12 month follow up, 18 month follow up]

    Self-reported perceived organizational level barriers. Lack of a) Time b) Routines for asking questions c) Routines for managing the response d) Preparedness at the workplace to care for victims of elder abuse

  8. Change between baseline and follow up concerning sense of responsibility, as reported in the questionnaire REAGERA-P [Baseline, Immediate post-intervention, 6 month follow up, 12 month follow up, 18 month follow up]

    Self reported sense of responsibility for asking questions about abuse (own responsibility, professions responsibility, health care system's responsibility)

  9. Change between baseline and follow up concerning level of awareness of abuse in contact with patients, as reported in the questionnaire REAGERA-P [Baseline, 12 month follow up]

    Patient case ("Vignette") with indicators of abuse present and participants self-report if they think they would have asked the patient questions about abuse

Other Outcome Measures

  1. Change between baseline and follow up concerning number of elder abuse victims identified at the clinics included in the study, as reported in the medical records [Baseline, 6 month follow up, 12 month follow up, 18 month follow up]

    Anonymous data from the medical records counting the number of older patients treated at each clinic that have been identified as victims of abuse during the last 6 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Employee at one of the clinics participating in the trial

  • Work tasks involves direct patient contact, at least part time

  • Participation at the training sessions

Exclusion Criteria:
  • Only administrative work and no direct patient contact

  • Not participating at the training session

Contacts and Locations

Locations

SiteCityStateCountryPostal Code
1Region Jönköpings länEksjöSweden
2Region Jönköpings LänJönköpingSweden
3Region ÖstergötlandLinköpingSweden
4Region ÖstergötlandNorrköpingSweden

Sponsors and Collaborators

  • Region Östergötland
  • Linkoeping University
  • Region Jönköping County
  • Linnaeus University

Investigators

  • Principal Investigator: Johanna Simmons, MD, PhD, Region Östergötland

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Johanna Simmons, Principal Investigator, Region Östergötland
ClinicalTrials.gov Identifier:
NCT05065281
Other Study ID Numbers:
  • RÖ-786
First Posted:
Oct 4, 2021
Last Update Posted:
Oct 8, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 8, 2021